Altered adipokine profile characterized by an increase in leptin concentration and a decrease in adiponectin levels was also described in NAFLD, thus indicating an additional common pathophysiological link between NAFLD and AH [78]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.